Skip to main content
Top
Published in: BMC Cancer 1/2008

Open Access 01-12-2008 | Research article

Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression

Authors: Nektaria Simiantonaki, Marios Taxeidis, Caren Jayasinghe, Ursula Kurzik-Dumke, Charles James Kirkpatrick

Published in: BMC Cancer | Issue 1/2008

Login to get access

Abstract

Background

Hypoxia-inducible factor 1 alpha (HIF-1α) is involved in processes promoting carcinogenesis of many tumors. However, its role in the development of colorectal cancer is unknown. To investigate the significance of HIF-1α during colorectal carcinogenesis and progression we examined its expression in precursor lesions constituting the conventional and serrated pathways, as well as in non-metastatic and metastatic adenocarcinomas.

Methods

Immunohistochemistry and Western blot is used to analyse HIF-1α expression in normal colonic mucosa, hyperplastic polyps (HPP), sessile serrated adenomas (SSA), low-grade (TA-LGD) and high-grade (TA-HGD) traditional adenomas as well as in non-metastatic and metastatic colorectal adenocarcinomas. Eight colorectal carcinoma cell lines are tested for their HIF-1α inducibility after lipopolysaccharide (LPS) stimulation using western blot and immunocytochemistry.

Results

In normal mucosa, HPP and TA-LGD HIF-1α was not expressed. In contast, perinuclear protein accumulation and nuclear expression of HIF-1α were shown in half of the examined SSA and TA-HGD. In all investigated colorectal carcinomas a significant nuclear HIF-1α overexpression compared to the premalignant lesions was observed but a significant correlation with the metastatic status was not found. Nuclear HIF-1α expression was strongly accumulated in perinecrotic regions. In these cases HIF-1α activation was seen in viable cohesive tumor epithelia surrounding necrosis and in dissociated tumor cells, which subsequently die. Enhanced distribution of HIF-1α was also seen in periiflammatory regions. In additional in vitro studies, treatment of diverse colorectal carcinoma cell lines with the potent pro-inflammatory factor lipopolysaccharide (LPS) led to HIF-1α expression and nuclear translocation.

Conclusion

We conclude that HIF-1α expression occurs in early stages of colorectal carcinogenesis and achieves a maximum in the invasive stage independent of the metastatic status. Perinecrotic activation of HIF-1α in invasive tumors underlines a dual role of HIF-1α by regulating both pro-survival and pro-death processes. HIF-1α up-regulation in response to LPS-mediated stimulation and periinflammatory expression in invasive carcinomas suggest its involvement in inflammatory events. These patterns of HIF-1α inducibility could contribute indirectly to the acquisition of a metastatic phenotype.
Appendix
Available only for authorised users
Literature
1.
go back to reference Harris AL: Hypoxia–a key regulatory factor in tumour growth. Nat Rev Cancer. 2002, 2: 38-47. 10.1038/nrc704.CrossRefPubMed Harris AL: Hypoxia–a key regulatory factor in tumour growth. Nat Rev Cancer. 2002, 2: 38-47. 10.1038/nrc704.CrossRefPubMed
2.
go back to reference Vaupel P: The role of hypoxia-induced factors in tumor progression. Oncologist. 2004, 9: 10-17. 10.1634/theoncologist.9-90005-10.CrossRefPubMed Vaupel P: The role of hypoxia-induced factors in tumor progression. Oncologist. 2004, 9: 10-17. 10.1634/theoncologist.9-90005-10.CrossRefPubMed
3.
4.
go back to reference Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL, Simons JW: Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 1999, 59: 5830-5835.PubMed Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL, Simons JW: Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 1999, 59: 5830-5835.PubMed
5.
go back to reference Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL: The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol. 2000, 157: 411-421.CrossRefPubMedPubMedCentral Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL: The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol. 2000, 157: 411-421.CrossRefPubMedPubMedCentral
6.
go back to reference Kuwai T, Kitadai Y, Tanaka S, Onogawa S, Matsutani N, Kaio E, Ito M, Chayama K: Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma. Int J Cancer. 2003, 105: 176-181. 10.1002/ijc.11068.CrossRefPubMed Kuwai T, Kitadai Y, Tanaka S, Onogawa S, Matsutani N, Kaio E, Ito M, Chayama K: Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma. Int J Cancer. 2003, 105: 176-181. 10.1002/ijc.11068.CrossRefPubMed
7.
go back to reference Jiang YA, Fan LF, Jiang CQ, Zhang YY, Luo HS, Tang ZJ, Xia D, Wang M: Expression and significance of PTEN, hypoxia-inducible factor-1 alpha in colorectal adenoma and adenocarcinoma. World J Gastroenterol. 2003, 9: 491-494.CrossRefPubMedPubMedCentral Jiang YA, Fan LF, Jiang CQ, Zhang YY, Luo HS, Tang ZJ, Xia D, Wang M: Expression and significance of PTEN, hypoxia-inducible factor-1 alpha in colorectal adenoma and adenocarcinoma. World J Gastroenterol. 2003, 9: 491-494.CrossRefPubMedPubMedCentral
8.
go back to reference Yoshimura H, Dhar DK, Kohno H, Kubota H, Fujii T, Ueda S, Kinugasa S, Tachibana M, Nagasue N: Prognostic impact of hypoxia-inducible factors 1alpha and 2alpha in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression. Clin Cancer Res. 2004, 10: 8554-8560. 10.1158/1078-0432.CCR-0946-03.CrossRefPubMed Yoshimura H, Dhar DK, Kohno H, Kubota H, Fujii T, Ueda S, Kinugasa S, Tachibana M, Nagasue N: Prognostic impact of hypoxia-inducible factors 1alpha and 2alpha in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression. Clin Cancer Res. 2004, 10: 8554-8560. 10.1158/1078-0432.CCR-0946-03.CrossRefPubMed
9.
go back to reference Koukourakis MI, Giatromanolaki A, Harris AL, Sivridis E: Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res. 2006, 66: 632-637. 10.1158/0008-5472.CAN-05-3260.CrossRefPubMed Koukourakis MI, Giatromanolaki A, Harris AL, Sivridis E: Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res. 2006, 66: 632-637. 10.1158/0008-5472.CAN-05-3260.CrossRefPubMed
10.
go back to reference Lu XG, Xing CG, Feng YZ, Chen J, Deng C: Clinical significance of immunohistochemical expression of hypoxia-inducible factor-1alpha as a prognostic marker in rectal adenocarcinoma. Clin Colorectal Cancer. 2006, 5: 350-353. 10.3816/CCC.2006.n.005.CrossRefPubMed Lu XG, Xing CG, Feng YZ, Chen J, Deng C: Clinical significance of immunohistochemical expression of hypoxia-inducible factor-1alpha as a prognostic marker in rectal adenocarcinoma. Clin Colorectal Cancer. 2006, 5: 350-353. 10.3816/CCC.2006.n.005.CrossRefPubMed
11.
go back to reference Yu JX, Cui L, Zhang QY, Chen H, Ji P, Wei HJ, Ma HY: Expression of NOS and HIF-1alpha in human colorectal carcinoma and implication in tumor angiogenesis. World J Gastroenterol. 2006, 12: 4660-4664.CrossRefPubMedPubMedCentral Yu JX, Cui L, Zhang QY, Chen H, Ji P, Wei HJ, Ma HY: Expression of NOS and HIF-1alpha in human colorectal carcinoma and implication in tumor angiogenesis. World J Gastroenterol. 2006, 12: 4660-4664.CrossRefPubMedPubMedCentral
12.
go back to reference Wincewicz A, Sulkowska M, Koda M, Sulkowski S: Clinicopathological significance and linkage of the distribution of HIF-1alpha and GLUT-1 in human primary colorectal cancer. Pathol Oncol Res. 2007, 13: 15-20.CrossRefPubMed Wincewicz A, Sulkowska M, Koda M, Sulkowski S: Clinicopathological significance and linkage of the distribution of HIF-1alpha and GLUT-1 in human primary colorectal cancer. Pathol Oncol Res. 2007, 13: 15-20.CrossRefPubMed
13.
go back to reference Zhong H, Semenza GL, Simons JW, De Marzo AM: Up-regulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis. Cancer Detect Prev. 2004, 28: 88-93. 10.1016/j.cdp.2003.12.009.CrossRefPubMed Zhong H, Semenza GL, Simons JW, De Marzo AM: Up-regulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis. Cancer Detect Prev. 2004, 28: 88-93. 10.1016/j.cdp.2003.12.009.CrossRefPubMed
14.
go back to reference Griffiths EA, Pritchard SA, Valentine HR, Whitchelo N, Bishop PW, Ebert MP, Price PM, Welch IM, West CM: Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas. Br J Cancer. 2007, 96: 95-103. 10.1038/sj.bjc.6603524.CrossRefPubMed Griffiths EA, Pritchard SA, Valentine HR, Whitchelo N, Bishop PW, Ebert MP, Price PM, Welch IM, West CM: Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas. Br J Cancer. 2007, 96: 95-103. 10.1038/sj.bjc.6603524.CrossRefPubMed
15.
go back to reference Bos R, Zhong H, Hanrahan CF, Mommers EC, Semenza GL, Pinedo HM, Abeloff MD, Simons JW, van Diest PJ, Wall van der E: Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst. 2001, 93: 309-314. 10.1093/jnci/93.4.309.CrossRefPubMed Bos R, Zhong H, Hanrahan CF, Mommers EC, Semenza GL, Pinedo HM, Abeloff MD, Simons JW, van Diest PJ, Wall van der E: Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst. 2001, 93: 309-314. 10.1093/jnci/93.4.309.CrossRefPubMed
16.
go back to reference Costa A, Coradini D, Carrassi A, Erdas R, Sardella A, Daidone MG: Re: Levels of hypoxia-inducible factor-1alpha during breast carcinogenesis. J Natl Cancer Inst. 2001, 93: 1175-1177. 10.1093/jnci/93.15.1175-a.CrossRefPubMed Costa A, Coradini D, Carrassi A, Erdas R, Sardella A, Daidone MG: Re: Levels of hypoxia-inducible factor-1alpha during breast carcinogenesis. J Natl Cancer Inst. 2001, 93: 1175-1177. 10.1093/jnci/93.15.1175-a.CrossRefPubMed
17.
go back to reference Acs G, Zhang PJ, McGrath CM, Acs P, McBroom J, Mohyeldin A, Liu S, Lu H, Verma A: Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Am J Pathol. 2003, 162: 1789-1806.CrossRefPubMedPubMedCentral Acs G, Zhang PJ, McGrath CM, Acs P, McBroom J, Mohyeldin A, Liu S, Lu H, Verma A: Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Am J Pathol. 2003, 162: 1789-1806.CrossRefPubMedPubMedCentral
18.
go back to reference Horrée N, van Diest PJ, Groep van der P, Sie-Go DM, Heintz AP: Hypoxia and angiogenesis in endometrioid endometrial carcinogenesis. Cell Oncol. 2007, 29: 219-227.PubMedPubMedCentral Horrée N, van Diest PJ, Groep van der P, Sie-Go DM, Heintz AP: Hypoxia and angiogenesis in endometrioid endometrial carcinogenesis. Cell Oncol. 2007, 29: 219-227.PubMedPubMedCentral
19.
go back to reference Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med. 1988, 319: 525-532.CrossRefPubMed Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med. 1988, 319: 525-532.CrossRefPubMed
20.
go back to reference Longacre TA, Fenoglio-Preiser CM: Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectalneoplasia. Am J Surg Pathol. 1990, 14: 524-537.CrossRefPubMed Longacre TA, Fenoglio-Preiser CM: Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectalneoplasia. Am J Surg Pathol. 1990, 14: 524-537.CrossRefPubMed
21.
go back to reference Frede S, Berchner-Pfannschmidt U, Fandrey J: Regulation of hypoxia-inducible factors during inflammation. Methods Enzymol. 2007, 435: 405-419.PubMed Frede S, Berchner-Pfannschmidt U, Fandrey J: Regulation of hypoxia-inducible factors during inflammation. Methods Enzymol. 2007, 435: 405-419.PubMed
22.
go back to reference Blouin CC, Pagé EL, Soucy GM, Richard DE: Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1alpha. Blood. 2004, 103: 1124-1130. 10.1182/blood-2003-07-2427.CrossRefPubMed Blouin CC, Pagé EL, Soucy GM, Richard DE: Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1alpha. Blood. 2004, 103: 1124-1130. 10.1182/blood-2003-07-2427.CrossRefPubMed
23.
go back to reference Frede S, Stockmann C, Freitag P, Fandrey J: Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB. Biochem J. 2006, 396: 517-527. 10.1042/BJ20051839.CrossRefPubMedPubMedCentral Frede S, Stockmann C, Freitag P, Fandrey J: Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB. Biochem J. 2006, 396: 517-527. 10.1042/BJ20051839.CrossRefPubMedPubMedCentral
24.
go back to reference Peyssonnaux C, Cejudo-Martin P, Doedens A, Zinkernagel AS, Johnson RS, Nizet V: Cutting edge: Essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis. J Immunol. 2007, 178: 7516-7519.CrossRefPubMed Peyssonnaux C, Cejudo-Martin P, Doedens A, Zinkernagel AS, Johnson RS, Nizet V: Cutting edge: Essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis. J Immunol. 2007, 178: 7516-7519.CrossRefPubMed
25.
go back to reference Liu XH, Kirschenbaum A, Lu M, Yao S, Dosoretz A, Holland JF, Levine AC: Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization andnuclear localization in a human prostate cancer cell line. J Biol Chem. 2002, 277: 50081-50086. 10.1074/jbc.M201095200.CrossRefPubMed Liu XH, Kirschenbaum A, Lu M, Yao S, Dosoretz A, Holland JF, Levine AC: Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization andnuclear localization in a human prostate cancer cell line. J Biol Chem. 2002, 277: 50081-50086. 10.1074/jbc.M201095200.CrossRefPubMed
26.
go back to reference Frede S, Freitag P, Otto T, Heilmaier C, Fandrey J: The proinflammatory cytokine interleukin 1beta and hypoxia cooperatively induce the expression of adrenomedullin in ovarian carcinoma cells through hypoxia inducible factor 1 activation. Cancer Res. 2005, 65: 4690-4697. 10.1158/0008-5472.CAN-04-3877.CrossRefPubMed Frede S, Freitag P, Otto T, Heilmaier C, Fandrey J: The proinflammatory cytokine interleukin 1beta and hypoxia cooperatively induce the expression of adrenomedullin in ovarian carcinoma cells through hypoxia inducible factor 1 activation. Cancer Res. 2005, 65: 4690-4697. 10.1158/0008-5472.CAN-04-3877.CrossRefPubMed
27.
go back to reference Morrison DC, Lei MG, Kirikae T, Chen TY: Endotoxin receptors on mammalian cells. Immunobiology. 1993, 187: 212-226.CrossRefPubMed Morrison DC, Lei MG, Kirikae T, Chen TY: Endotoxin receptors on mammalian cells. Immunobiology. 1993, 187: 212-226.CrossRefPubMed
28.
go back to reference Simiantonaki N, Kurzik-Dumke U, Karyofylli G, Jayasinghe C, Michel-Schmidt R, Kirkpatrick CJ: Reduced expression of TLR4 is associated with the metastatic status of human colorectal cancer. Int J Mol Med. 2007, 20: 21-29.PubMed Simiantonaki N, Kurzik-Dumke U, Karyofylli G, Jayasinghe C, Michel-Schmidt R, Kirkpatrick CJ: Reduced expression of TLR4 is associated with the metastatic status of human colorectal cancer. Int J Mol Med. 2007, 20: 21-29.PubMed
29.
go back to reference Simiantonaki N, Kurzik-Dumke U, Karyofylli G, Jayasinghe C, Kirkpatrick CJ: Loss of E-cadherin in the vicinity of necrosis in colorectal carcinomas:association with NFkappaB expression. Int J Oncol. 2007, 31: 269-275.PubMed Simiantonaki N, Kurzik-Dumke U, Karyofylli G, Jayasinghe C, Kirkpatrick CJ: Loss of E-cadherin in the vicinity of necrosis in colorectal carcinomas:association with NFkappaB expression. Int J Oncol. 2007, 31: 269-275.PubMed
30.
go back to reference Simiantonaki N, Jayasinghe C, Kirkpatrick CJ: Effect of pro-inflammatory stimuli on tumor cell-mediated induction of endothelial cell adhesion molecules in vitro. Exp Mol Pathol. 2002, 73: 46-53. 10.1006/exmp.2002.2440.CrossRefPubMed Simiantonaki N, Jayasinghe C, Kirkpatrick CJ: Effect of pro-inflammatory stimuli on tumor cell-mediated induction of endothelial cell adhesion molecules in vitro. Exp Mol Pathol. 2002, 73: 46-53. 10.1006/exmp.2002.2440.CrossRefPubMed
31.
go back to reference Koury J, Deitch EA, Homma H, Abungu B, Gangurde P, Condon MR, Lu Q, Xu DZ, Feinman R: Persistent HIF-1alpha activation in gut ischemia/reperfusion injury: potential role of bacteria and lipopolysaccharide. Shock. 2004, 22: 270-277. 10.1097/01.shk.0000135256.67441.3f.CrossRefPubMed Koury J, Deitch EA, Homma H, Abungu B, Gangurde P, Condon MR, Lu Q, Xu DZ, Feinman R: Persistent HIF-1alpha activation in gut ischemia/reperfusion injury: potential role of bacteria and lipopolysaccharide. Shock. 2004, 22: 270-277. 10.1097/01.shk.0000135256.67441.3f.CrossRefPubMed
32.
go back to reference Huang LE, Bindra RS, Glazer PM, Harris AL: Hypoxia-induced genetic instability–a calculated mechanism underlying tumor progression. J Mol Med. 2007, 85: 139-148. 10.1007/s00109-006-0133-6.CrossRefPubMed Huang LE, Bindra RS, Glazer PM, Harris AL: Hypoxia-induced genetic instability–a calculated mechanism underlying tumor progression. J Mol Med. 2007, 85: 139-148. 10.1007/s00109-006-0133-6.CrossRefPubMed
33.
34.
go back to reference Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, Zeng Q, Dillehay LE, Madan A, Semenza GL, Bedi A: Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev. 2000, 14: 34-44.PubMedPubMedCentral Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, Zeng Q, Dillehay LE, Madan A, Semenza GL, Bedi A: Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev. 2000, 14: 34-44.PubMedPubMedCentral
35.
go back to reference Sugai T, Habano W, Uesugi N, Jiao YF, Nakamura S, Sato K, Chiba T, Ishii M: Molecular validation of the modified Vienna classification of colorectal tumors. J Mol Diagn. 2002, 4: 191-200.CrossRefPubMedPubMedCentral Sugai T, Habano W, Uesugi N, Jiao YF, Nakamura S, Sato K, Chiba T, Ishii M: Molecular validation of the modified Vienna classification of colorectal tumors. J Mol Diagn. 2002, 4: 191-200.CrossRefPubMedPubMedCentral
36.
go back to reference Beach R, Chan AO, Wu TT, White JA, Morris JS, Lunagomez S, Broaddus RR, Issa JP, Hamilton SR, Rashid A: BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am J Pathol. 2005, 166: 1069-1075.CrossRefPubMedPubMedCentral Beach R, Chan AO, Wu TT, White JA, Morris JS, Lunagomez S, Broaddus RR, Issa JP, Hamilton SR, Rashid A: BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am J Pathol. 2005, 166: 1069-1075.CrossRefPubMedPubMedCentral
37.
go back to reference Jass JR, Baker K, Zlobec I, Higuchi T, Barker M, Buchanan D, Young J: Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer. Histopathology. 2006, 49: 121-131. 10.1111/j.1365-2559.2006.02466.x.CrossRefPubMedPubMedCentral Jass JR, Baker K, Zlobec I, Higuchi T, Barker M, Buchanan D, Young J: Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer. Histopathology. 2006, 49: 121-131. 10.1111/j.1365-2559.2006.02466.x.CrossRefPubMedPubMedCentral
38.
go back to reference Konishi K, Yamochi T, Makino R, Kaneko K, Yamamoto T, Nozawa H, Katagiri A, Ito H, Nakayama K, Ota H, Mitamura K, Imawari M: Molecular differences between sporadic serrated and conventional colorectal adenomas. Clin Cancer Res. 2004, 10: 3082-3090. 10.1158/1078-0432.CCR-03-0334.CrossRefPubMed Konishi K, Yamochi T, Makino R, Kaneko K, Yamamoto T, Nozawa H, Katagiri A, Ito H, Nakayama K, Ota H, Mitamura K, Imawari M: Molecular differences between sporadic serrated and conventional colorectal adenomas. Clin Cancer Res. 2004, 10: 3082-3090. 10.1158/1078-0432.CCR-03-0334.CrossRefPubMed
39.
go back to reference Kumar SM, Yu H, Edwards R, Chen L, Kazianis S, Brafford P, Acs G, Herlyn M, Xu Xl: Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma. Cancer Res. 2007, 67: 3177-3184. 10.1158/0008-5472.CAN-06-3312.CrossRefPubMed Kumar SM, Yu H, Edwards R, Chen L, Kazianis S, Brafford P, Acs G, Herlyn M, Xu Xl: Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma. Cancer Res. 2007, 67: 3177-3184. 10.1158/0008-5472.CAN-06-3312.CrossRefPubMed
40.
go back to reference Jass JR: Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat Clin Pract Oncol. 2005, 2: 398-405. 10.1038/ncponc0248.CrossRefPubMed Jass JR: Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat Clin Pract Oncol. 2005, 2: 398-405. 10.1038/ncponc0248.CrossRefPubMed
41.
go back to reference Young J, Simms LA, Biden KG, Wynter C, Whitehall V, Karamatic R, George J, Goldblatt J, Walpole I, Robin SA, et al: Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol. 2001, 159: 2107-2116.CrossRefPubMedPubMedCentral Young J, Simms LA, Biden KG, Wynter C, Whitehall V, Karamatic R, George J, Goldblatt J, Walpole I, Robin SA, et al: Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol. 2001, 159: 2107-2116.CrossRefPubMedPubMedCentral
42.
go back to reference Mihaylova VT, Bindra RS, Yuan J, Campisi D, Narayanan L, Jensen R, Giordano F, Johnson RS, Rockwell S, Glazer PM: Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells. Mol Cell Biol. 2003, 23: 3265-73. 10.1128/MCB.23.9.3265-3273.2003.CrossRefPubMedPubMedCentral Mihaylova VT, Bindra RS, Yuan J, Campisi D, Narayanan L, Jensen R, Giordano F, Johnson RS, Rockwell S, Glazer PM: Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells. Mol Cell Biol. 2003, 23: 3265-73. 10.1128/MCB.23.9.3265-3273.2003.CrossRefPubMedPubMedCentral
43.
go back to reference Krishnamachary B, Berg-Dixon S, Kelly B, Agani F, Feldser D, Ferreira G, Iyer N, LaRusch J, Pak B, Taghavi P, Semenza GL: Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res. 2003, 63: 1138-1143.PubMed Krishnamachary B, Berg-Dixon S, Kelly B, Agani F, Feldser D, Ferreira G, Iyer N, LaRusch J, Pak B, Taghavi P, Semenza GL: Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res. 2003, 63: 1138-1143.PubMed
44.
go back to reference Zhou J, Schmid T, Schnitzer S, Brüne B: Tumor hypoxia and cancer progression. Cancer Lett. 2006, 237: 10-21. 10.1016/j.canlet.2005.05.028.CrossRefPubMed Zhou J, Schmid T, Schnitzer S, Brüne B: Tumor hypoxia and cancer progression. Cancer Lett. 2006, 237: 10-21. 10.1016/j.canlet.2005.05.028.CrossRefPubMed
45.
go back to reference Schoeffel U, Pelz K, Häring RU, Amberg R, Schandl R, Urbaschek R, von Specht BU, Farthmann EH: Inflammatory consequences of the translocation of bacteria and endotoxin to mesenteric lymph nodes. Am J Surg. 2000, 180: 65-72. 10.1016/S0002-9610(00)00410-4.CrossRefPubMed Schoeffel U, Pelz K, Häring RU, Amberg R, Schandl R, Urbaschek R, von Specht BU, Farthmann EH: Inflammatory consequences of the translocation of bacteria and endotoxin to mesenteric lymph nodes. Am J Surg. 2000, 180: 65-72. 10.1016/S0002-9610(00)00410-4.CrossRefPubMed
46.
go back to reference Balkwill F, Mantovani A: Inflammation and cancer: back to Virchow?. Lancet. 2001, 357: 539-545. 10.1016/S0140-6736(00)04046-0.CrossRefPubMed Balkwill F, Mantovani A: Inflammation and cancer: back to Virchow?. Lancet. 2001, 357: 539-545. 10.1016/S0140-6736(00)04046-0.CrossRefPubMed
47.
go back to reference Simiantonaki N, Jayasinghe C, Michel-Schmidt R, Peters K, Hermanns MI, Kirkpatrick CJ: Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines. Int J Oncol. 2008, 32: 585-592.PubMed Simiantonaki N, Jayasinghe C, Michel-Schmidt R, Peters K, Hermanns MI, Kirkpatrick CJ: Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines. Int J Oncol. 2008, 32: 585-592.PubMed
Metadata
Title
Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression
Authors
Nektaria Simiantonaki
Marios Taxeidis
Caren Jayasinghe
Ursula Kurzik-Dumke
Charles James Kirkpatrick
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2008
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-8-320

Other articles of this Issue 1/2008

BMC Cancer 1/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine